A leader in antibody drugs in China with capabilities in research and development, manufacturing and commercialization.
At present, the company has a marketing and sales team with 550 experienced sales professionals in China, covering more than 5,200 medical institutions in all provinces, autonomous regions and municipalities, including more than 1,600 top-tier hospitals. Etanercept has been registered and marketed in 15 countries around the world and exported to overseas markets.
South American markets
El Salvador, Paraguay,
Panama, Ecuador and Bolivia
China, India, Pakistan,
Myanmar, Cambodia and Bangladesh, Indonesia